Benefits of High-level Disinfection
(HLD)
Sustainable
Savings realized
from reprocessing
can be reinvested to
advance patient
care initiatives
Delivers savings over OEM
products and up to 2x savings
over EtO reprocessing
Cost-effective
HLD is a non-toxic
process that
doesn't use
toxic EtO
Additional savings realized
through decreased waste
disposal costs, inventory
reduction, and reduced
freight premiums
A high-temperature,
water-based process
with no harmful
air emissions
Safe
No chemicals
or carcinogens
100% of products are
functionally and visually
tested post-reprocessing
Devices look, feel
and function as
brand new
R E F E R E N C E S:
1. Office of Device Evaluation, US Food and Drug Administration. Section 510(k) Summary No. K031559. November 12, 2003. 2. Office of
Device Evaluation, US Food and Drug Administration. Section 510(k) Summary No. K051227. April 6, 2006. 3. Office of Device Evaluation,
US Food and Drug Administration. Section 510(k) Summary No. K093658. January 14, 2010. 4. Office of Device Evaluation, US Food and
Drug Administration. Section 510(k) Summary No. K121145. June 12, 2012.
19 US_ArjoPure_SCS&S ad 062119
Enhance the life of
devices by providing
more cycles and
less landfill waste
